McKesson Life Sciences

*** Live: Thursday, Oct. 29, 2020 at 2pm EDT | 1pm CDT | 11am PDT*** E Get a behind the scenes look into the community oncology provider world through the COVID-19 emergence. Understand provider education needs and preferences and formulate effective strategies to deliver education most adapted to their needs in a virtual world. ***On demand available after final airing until Oct. 29, 2021***

In today’s evolving, value-based environment for specialty drugs, high-touch services that enhance patient outcomes are playing an increasingly important role in market access and patient care delivery. Using gene therapy as a specific example, this white paper will discuss many of the high-touch services that can help enhance patient outcomes.

Biopharma companies see a need to provide the same kind of patient access and hub services that patients, prescribers and payers have come to expect. But their design must evolve along to get patients on treatments quickly to maximize their outcome, commitment and satisfaction with care.

How biopharma companies can pursue multiple channels to enhance access to segmented markets.